Results 51 to 60 of about 3,391 (207)

Treatment approaches in posthypoxic myoclonus: A narrative review with expert opinion

open access: yesEpilepsia, Volume 67, Issue 3, Page 1049-1065, March 2026.
Abstract Acute posthypoxic myoclonus (PHM) is a neurological complication that typically emerges within 12–48 h following cardiac arrest, often in comatose patients. It can present as generalized, multifocal, or focal myoclonus and has traditionally been associated with poor prognosis.
Marina Romozzi   +7 more
wiley   +1 more source

Piracetam Co-Crystals with OH-Group Functionalized Carboxylic Acids

open access: yes, 2016
We report the synthesis, crystal structures, and basic physicochemical properties of six co-crystals of piracetam. Co-crystals of piracetam with l-tartaric acid, with citric acid in a 1:1 and 3:2 ratio, with racemic mandelic acid, and with l-mandelic ...
Fritz Blatter (2376541)   +3 more
core   +1 more source

Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function

open access: yesNeural Plasticity, 2016
The mitochondrial cascade hypothesis of dementia assumes mitochondrial dysfunction leading to reduced energy supply, impaired neuroplasticity, and finally cell death as one major pathomechanism underlying the continuum from brain aging over mild ...
Carola Stockburger   +4 more
doaj   +1 more source

Epilepsy in dentatorubral–pallidoluysian atrophy: A systematic review and meta‐analysis

open access: yesEpilepsia, Volume 67, Issue 2, Page 696-711, February 2026.
Summary of key clinical and electrophysiological characteristics of DRPLA‐related epilepsy from a systematic review and meta‐analysis of 1,191 patients. DRPLA patients with epilepsy showed earlier disease onset, longer CAG repeat expansion, and a tendency toward paternal inheritance. EEG findings frequently included photoparoxysmal responses.
Toru Horinouchi   +10 more
wiley   +1 more source

POSSIBILITIES TO USE A FIXED COMBINATION OF PIRACETAM AND CINNARIZINE IN NEUROLOGICAL PRACTICE

open access: yesМедицинский совет, 2017
The article discusses  the  possibility of using the  complex drug Phezam, containing 400  mg of Piracetam and 25  mg of Cinnarizine in neurological practice.
N. V. Titova
doaj   +1 more source

Piracetam for acute ischaemic stroke [PDF]

open access: yesCochrane Database of Systematic Reviews, 2002
Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acute stroke.The objective of this review was to assess the effects of piracetam in acute presumed ischaemic stroke.We searched the Cochrane Stroke Review Group trials register, Medline (from 1965), Embase (from 1980), BIDIS ISI (from ...
Stefano, Ricci   +3 more
openaire   +5 more sources

Piracetam for fetal distress in labour [PDF]

open access: yesCochrane Database of Systematic Reviews, 1998
Piracetam is thought to promote the metabolism of brain cells when they are hypoxic. It has been used to prevent adverse effects of fetal distress.The objective of this review was to assess the effects of piracetam for suspected fetal distress in labour on method of delivery and perinatal morbidity.The Cochrane Pregnancy and Childbirth Group trials ...
G Justus, Hofmeyr, Regina, Kulier
openaire   +4 more sources

Physiological disposition of oral piracetam in Sprague-Dawley rats

open access: yes, 1984
The distribution and fate of piracetam (2-oxo-1-pyrrolidine acetamide, Nootropil), the prototype ‘nootropic drug’, was examined in rats given 100–1000 mg kg−1 by gavage, with or without [3H]piracetam as a tracer.
Maria T Tacconi, Richard J Wurtman
core   +1 more source

Stability of piracetam in solid pharmaceutical forms [PDF]

open access: yes, 2023
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroducere. Formele farmaceutice solide (comprimatele, capsulele) sunt preferate pentru administrarea piracetamului (medicament nootrop).
Cereniuc, Alina   +3 more
core  

Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl.

open access: yesMedičnì Perspektivi, 2018
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of com­bined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical ...
V. I. Mamchur, S. N. Dronov
doaj   +1 more source

Home - About - Disclaimer - Privacy